24 Oct 2023 Oncology & Hematology P-REALITY-X: Real-world evaluation of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer
9 Oct 2023 Diabetes & Endocrinology Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease
28 Sep 2023 Oncology & Hematology Safety and efficacy darolutamide in Black/African-American patients in the ARAMIS study
20 Sep 2023 Oncology & Hematology Prognostic value of MRD dynamics during maintenance therapy for multiple myeloma in the TOURMALINE-MM3 and -MM4 trials
12 Sep 2023 Immunology & Immunotherapy VOLTAIRE-RA and VOLTAIRE-RA extension: Clinical equivalence studies of BI 695501 (Cyltezo®; adalimumab-adbm) and adalimumab reference product in rheumatoid arthritis
19 Jul 2023 Oncology & Hematology Hedgehog inhibitors for basal cell carcinoma: real-world treatment patterns
13 Jun 2023 Immunology & Immunotherapy VOLTAIRE-CD: A phase III study of BI 695501 versus adalimumab reference product in patients with Crohn’s disease
20 Sep 2023 Oncology & Hematology Prognostic value of MRD dynamics during maintenance therapy for multiple myeloma in the TOURMALINE-MM3 and -MM4 trials
22 Nov 2021 Rare Diseases Plain language summary: Vosoritide treatment accelerates bone growth in children with achondroplasia
11 Nov 2019 Neurology & Psychiatry A first-in-human, gene-silencing treatment for Alzheimer’s disease with Catherine Mummery
16 Aug 2021 Dermatology When should a PCP refer a patient with pustular psoriasis to a dermatologist?
19 Jul 2023 Oncology & Hematology Hedgehog inhibitors for basal cell carcinoma: real-world treatment patterns
13 Jun 2023 Immunology & Immunotherapy VOLTAIRE-CD: A phase III study of BI 695501 versus adalimumab reference product in patients with Crohn’s disease
